Press Release - All

• 17 Nov 2021
  Agilent Increases Cash Dividend to 21 Cents per Share
• 02 Nov 2021
  Agilent Names John Palma to Lead Global Medical Affairs Organization
• 01 Nov 2021
  Agilent Announces New Ion Mobility LC/Q-TOF and Enhanced Solutions for Biotherapeutics at ASMS 2021
• 28 Oct 2021
  Agilent to Webcast Fourth-Quarter Fiscal Year 2021 Financial Results Presentation
• 28 Oct 2021
  Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Triple-Negative Breast Cancer (TNBC)
• 27 Oct 2021
  Agilent Commits to Net-Zero Greenhouse Gas Emissions by 2050
• 26 Oct 2021
  Agilent Announced as My Green Lab’s First ‘Transformative Level’ Sponsor and First Sponsor of the My Green Lab Certification Program
• 21 Oct 2021
  Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
• 13 Oct 2021
  Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer
• 28 Sep 2021
  Agilent Announces Thought Leader Award to Bernhard Lendl at the TU Wien (Vienna)